| mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-06 |
| mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.2 |
2e-06 |
| mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
| mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
3e-06 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
3e-06 |
| mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.24 |
3e-06 |
| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
6e-06 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-06 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |